Cargando…

Quantitative whole-cell MALDI-TOF MS fingerprints distinguishes human monocyte sub-populations activated by distinct microbial ligands

BACKGROUND: Conventionally, human monocyte sub-populations are classified according to surface marker expression into classical (CD14(++)CD16(−)), intermediate (CD14(++)CD16(+)) and non-classical (CD14(+)CD16(++)) lineages. The involvement of non-classical monocytes, also referred to as proinflammat...

Descripción completa

Detalles Bibliográficos
Autores principales: Portevin, Damien, Pflüger, Valentin, Otieno, Patricia, Brunisholz, René, Vogel, Guido, Daubenberger, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425930/
https://www.ncbi.nlm.nih.gov/pubmed/25887592
http://dx.doi.org/10.1186/s12896-015-0140-1
_version_ 1782370547220348928
author Portevin, Damien
Pflüger, Valentin
Otieno, Patricia
Brunisholz, René
Vogel, Guido
Daubenberger, Claudia
author_facet Portevin, Damien
Pflüger, Valentin
Otieno, Patricia
Brunisholz, René
Vogel, Guido
Daubenberger, Claudia
author_sort Portevin, Damien
collection PubMed
description BACKGROUND: Conventionally, human monocyte sub-populations are classified according to surface marker expression into classical (CD14(++)CD16(−)), intermediate (CD14(++)CD16(+)) and non-classical (CD14(+)CD16(++)) lineages. The involvement of non-classical monocytes, also referred to as proinflammatory monocytes, in the pathophysiology of diseases including diabetes mellitus, atherosclerosis or Alzheimer’s disease is well recognized. The development of novel high-throughput methods to capture functional states within the different monocyte lineages at the whole cell proteomic level will enable real time monitoring of disease states. RESULTS: We isolated and characterized (pan-) monocytes, mostly composed of classical CD16(−) monocytes, versus autologous CD16(+) subpopulations from the blood of healthy human donors (n = 8) and compared their inflammatory properties in response to lipopolysaccharides and M.tuberculosis antigens by multiplex cytokine profiling. Following resting and in vitro antigenic stimulation, cells were recovered and subjected to whole-cell mass spectrometry analysis. This approach identified the specific presence/absence of m/z peaks and therefore potential biomarkers that can discriminate pan-monocytes from their CD16 counterparts. Furthermore, we found that semi-quantitative data analysis could capture the subtle proteome changes occurring upon microbial stimulation that differentiate resting, from lipopolysaccharides or M. tuberculosis stimulated monocytic samples. CONCLUSIONS: Whole-cell mass spectrometry fingerprinting could efficiently distinguish monocytic sub-populations that arose from a same hematopoietic lineage. We also demonstrate for the first time that mass spectrometry signatures can monitor semi-quantitatively specific activation status in response to exogenous stimulation. As such, this approach stands as a fast and efficient method for the applied immunology field to assess the reactivity of potentially any immune cell types that may sustain health or promote related inflammatory diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12896-015-0140-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4425930
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44259302015-05-10 Quantitative whole-cell MALDI-TOF MS fingerprints distinguishes human monocyte sub-populations activated by distinct microbial ligands Portevin, Damien Pflüger, Valentin Otieno, Patricia Brunisholz, René Vogel, Guido Daubenberger, Claudia BMC Biotechnol Research Article BACKGROUND: Conventionally, human monocyte sub-populations are classified according to surface marker expression into classical (CD14(++)CD16(−)), intermediate (CD14(++)CD16(+)) and non-classical (CD14(+)CD16(++)) lineages. The involvement of non-classical monocytes, also referred to as proinflammatory monocytes, in the pathophysiology of diseases including diabetes mellitus, atherosclerosis or Alzheimer’s disease is well recognized. The development of novel high-throughput methods to capture functional states within the different monocyte lineages at the whole cell proteomic level will enable real time monitoring of disease states. RESULTS: We isolated and characterized (pan-) monocytes, mostly composed of classical CD16(−) monocytes, versus autologous CD16(+) subpopulations from the blood of healthy human donors (n = 8) and compared their inflammatory properties in response to lipopolysaccharides and M.tuberculosis antigens by multiplex cytokine profiling. Following resting and in vitro antigenic stimulation, cells were recovered and subjected to whole-cell mass spectrometry analysis. This approach identified the specific presence/absence of m/z peaks and therefore potential biomarkers that can discriminate pan-monocytes from their CD16 counterparts. Furthermore, we found that semi-quantitative data analysis could capture the subtle proteome changes occurring upon microbial stimulation that differentiate resting, from lipopolysaccharides or M. tuberculosis stimulated monocytic samples. CONCLUSIONS: Whole-cell mass spectrometry fingerprinting could efficiently distinguish monocytic sub-populations that arose from a same hematopoietic lineage. We also demonstrate for the first time that mass spectrometry signatures can monitor semi-quantitatively specific activation status in response to exogenous stimulation. As such, this approach stands as a fast and efficient method for the applied immunology field to assess the reactivity of potentially any immune cell types that may sustain health or promote related inflammatory diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12896-015-0140-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-11 /pmc/articles/PMC4425930/ /pubmed/25887592 http://dx.doi.org/10.1186/s12896-015-0140-1 Text en © Portevin et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Portevin, Damien
Pflüger, Valentin
Otieno, Patricia
Brunisholz, René
Vogel, Guido
Daubenberger, Claudia
Quantitative whole-cell MALDI-TOF MS fingerprints distinguishes human monocyte sub-populations activated by distinct microbial ligands
title Quantitative whole-cell MALDI-TOF MS fingerprints distinguishes human monocyte sub-populations activated by distinct microbial ligands
title_full Quantitative whole-cell MALDI-TOF MS fingerprints distinguishes human monocyte sub-populations activated by distinct microbial ligands
title_fullStr Quantitative whole-cell MALDI-TOF MS fingerprints distinguishes human monocyte sub-populations activated by distinct microbial ligands
title_full_unstemmed Quantitative whole-cell MALDI-TOF MS fingerprints distinguishes human monocyte sub-populations activated by distinct microbial ligands
title_short Quantitative whole-cell MALDI-TOF MS fingerprints distinguishes human monocyte sub-populations activated by distinct microbial ligands
title_sort quantitative whole-cell maldi-tof ms fingerprints distinguishes human monocyte sub-populations activated by distinct microbial ligands
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425930/
https://www.ncbi.nlm.nih.gov/pubmed/25887592
http://dx.doi.org/10.1186/s12896-015-0140-1
work_keys_str_mv AT portevindamien quantitativewholecellmalditofmsfingerprintsdistinguisheshumanmonocytesubpopulationsactivatedbydistinctmicrobialligands
AT pflugervalentin quantitativewholecellmalditofmsfingerprintsdistinguisheshumanmonocytesubpopulationsactivatedbydistinctmicrobialligands
AT otienopatricia quantitativewholecellmalditofmsfingerprintsdistinguisheshumanmonocytesubpopulationsactivatedbydistinctmicrobialligands
AT brunisholzrene quantitativewholecellmalditofmsfingerprintsdistinguisheshumanmonocytesubpopulationsactivatedbydistinctmicrobialligands
AT vogelguido quantitativewholecellmalditofmsfingerprintsdistinguisheshumanmonocytesubpopulationsactivatedbydistinctmicrobialligands
AT daubenbergerclaudia quantitativewholecellmalditofmsfingerprintsdistinguisheshumanmonocytesubpopulationsactivatedbydistinctmicrobialligands